BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24203724)

  • 1. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
    Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
    Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No extreme genetic risk for type 1 diabetes among DR3/4-DQ8 siblings sharing both extended HLA haplotypes with their diabetic proband.
    Eerligh P; Koeleman BP; Lie BA; Roep BO; Thorsby E
    Tissue Antigens; 2011 Apr; 77(4):338-40. PubMed ID: 21388358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme genetic risk for type 1A diabetes.
    Aly TA; Ide A; Jahromi MM; Barker JM; Fernando MS; Babu SR; Yu L; Miao D; Erlich HA; Fain PR; Barriga KJ; Norris JM; Rewers MJ; Eisenbarth GS
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14074-9. PubMed ID: 16966600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.
    Ide A; Babu SR; Robles DT; Wang T; Erlich HA; Bugawan TL; Rewers M; Fain PR; Eisenbarth GS
    J Clin Immunol; 2005 Jul; 25(4):303-8. PubMed ID: 16133985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study.
    Rasmussen T; Witsø E; Tapia G; Stene LC; Rønningen KS
    Diabetes Metab Res Rev; 2011 Nov; 27(8):834-7. PubMed ID: 22069269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
    Törn C; Hillman M; Sanjeevi CB; Landin-Olsson M
    Hum Immunol; 2006 Jul; 67(7):527-34. PubMed ID: 16829307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
    Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
    Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
    Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.
    Törn C; Gupta M; Nikitina Zake L; Sanjeevi CB; Landin-Olsson M
    Hum Immunol; 2003 Sep; 64(9):902-9. PubMed ID: 12941547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R; Gombos Z; Gyürüs E; Soltész G
    Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes.
    Undlien DE; Kockum I; Rønningen KS; Lowe R; Saanjeevi CB; Graham J; Lie BA; Akselsen HE; Lernmark A; Thorsby E
    Tissue Antigens; 1999 Dec; 54(6):543-51. PubMed ID: 10674967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies.
    Robles DT; Eisenbarth GS; Wang T; Erlich HA; Bugawan TL; Babu SR; Barriga K; Norris JM; Hoffman M; Klingensmith G; Yu L; Rewers M;
    Clin Immunol; 2002 Mar; 102(3):217-24. PubMed ID: 11890708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
    Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
    Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.
    Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B
    Autoimmunity; 2016 Jun; 49(4):240-7. PubMed ID: 27138053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of pediatric celiac disease according to HLA haplotype and country.
    Liu E; Lee HS; Aronsson CA; Hagopian WA; Koletzko S; Rewers MJ; Eisenbarth GS; Bingley PJ; Bonifacio E; Simell V; Agardh D;
    N Engl J Med; 2014 Jul; 371(1):42-9. PubMed ID: 24988556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes.
    Hannelius U; Beam CA; Ludvigsson J
    Diabetologia; 2020 Oct; 63(10):2177-2181. PubMed ID: 32754804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
    Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.